Search

Displaying results 8621 - 8630 of 10000 in total
  1. Drug

    Vanucizumab

    go.drugbank.com/drugs/DB12317
    Investigational

    Vanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.

  2. Drug

    Somavaratan

    go.drugbank.com/drugs/DB12421
    Investigational

    Somavaratan has been used in trials studying the treatment of Growth Disorders and Adult Growth Hormone Deficiency.

  3. Drug

    Verdiperstat

    go.drugbank.com/drugs/DB12440
    Investigational

    Verdiperstat has been used in trials studying the basic science and treatment of Multiple System Atrophy (MSA).

  4. Drug

    Tovetumab

    go.drugbank.com/drugs/DB12609
    Investigational

    Tovetumab has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Advanced Solid Malignancies.

  5. Drug

    BMS-188797

    go.drugbank.com/drugs/DB12619
    Investigational

    BMS-188797 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  6. Drug

    Aclerastide

    go.drugbank.com/drugs/DB12631
    Investigational

    Aclerastide has been investigated for the treatment of Diabetic Foot, Diabetic Foot Ulcers, and Foot Ulcer, Diabetic.

  7. Drug

    Ibipinabant

    go.drugbank.com/drugs/DB12649
    Investigational

    Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.

    Categories: Cannabinoid Receptor Antagonists, Receptor, Cannabinoid, CB1, antagonists & inhibitors
  8. Drug

    Methylselenocysteine

    go.drugbank.com/drugs/DB12697
    Investigational

    Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.

    Synonyms: SE-METHYL-SELENO-L-CYSTEINE
  9. Drug

    Omipalisib

    go.drugbank.com/drugs/DB12703
    Investigational

    Omipalisib has been used in trials studying the treatment of CANCER, Solid Tumours, and Idiopathic Pulmonary Fibrosis.

  10. Drug

    Sacituzumab tirumotecan

    go.drugbank.com/drugs/DB18777
    Investigational

    Sacituzumab tirumotecan is a recombinant humanized IgG1 anti-TROP2 monoclonal antibody conjugated to a topoisomerase I inhibitor.